Back to Top
J2P-MC-LXBD Screenshot 0
J2P-MC-LXBD Screenshot 1
J2P-MC-LXBD Screenshot 2
J2P-MC-LXBD Screenshot 3
Free website generator for mobile apps; privacy policy, app-ads.txt support and more... AppPage.net

About J2P-MC-LXBD

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain.

Similar Apps

Novavax_2019nCoV-205 Diary

Novavax_2019nCoV-205 Diary

0.0

You are invited to participate in the Novavax_2019nCoV-205study. This app is specifically...

Medable Participant App

Medable Participant App

4.4

Today’s rapidly changing healthcare landscape presents new challenges and disruptions to patient...

ZEUS Study App (EX6018-4758)

ZEUS Study App (EX6018-4758)

0.0

This app is specifically intended for study participants in the ZEUS (EX6018-4758)...

W8M-MC-OXA1

W8M-MC-OXA1

0.0

A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions...

Option VMS

Option VMS

0.0

You are invited to participate in the Option VMS study....

Pegasus FLY

Pegasus FLY

0.0

Welcome to your Pegasus FLY patient application. This application is designed for...